Evidence for investigating GSK-3 inhibitors as potential therapeutics for severe COVID-19. Ghazanfari D, Courreges MC, Belinski L, Bergmeier SC, et al. Biochem Biophys Res Commun 2022;605:171-176.

Read + Share

Amedeo Smart

Independent Medical Education

Ghazanfari D, Courreges MC, Belinski L, Bergmeier SC, et al. Evidence for investigating GSK-3 inhibitors as potential therapeutics for severe COVID-19. Biochem Biophys Res Commun 2022;605:171-176.
PMID: 35367865